Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAnalyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Company Earnings Date And Information
The company last posted its earnings results on Friday, August 9th, 2024. The company reported $-1.04 earnings per share for the quarter, missing analysts' consensus estimates of $-0.15 by $0.89. The company had revenue of 431.01 M for the quarter and had revenue of 431.61 M for the year. The company has generated $-3 earnings per share over the last year ($-2.7 diluted earnings per share) and currently has a price-to-earnings ratio of -0.03. The company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q4 2025 | N/A | -$1.70 | N/A | N/A | $431.01 M |
| 11/12/2025 | Q3 2025 | N/A | -$0.19 | N/A | N/A | $590.05 K |
| 08/12/2025 | Q2 2025 | N/A | -$0.48 | N/A | N/A | $0 |
| 05/12/2025 | Q1 2025 | N/A | -$0.65 | N/A | N/A | $10.26 K |
| 03/25/2025 | Q4 2024 | N/A | $13.47 | N/A | $2.54 M | $53.08 K |
| 11/06/2024 | Q3 2024 | N/A | -$1.34 | N/A | $2.48 M | $64.86 K |
| 08/09/2024 | Q2 2024 | -$0.15 | -$1.30 | -1.15 | $2.24 M | $18.70 K |
| 06/26/2024 | Q1 2024 | -$0.15 | -$8.14 | -7.99 | N/A | $0 |
| 05/03/2024 | Q4 2023 | N/A | -$12.57 | N/A | N/A | $2.35 M |
| 01/16/2024 | Q3 2023 | -$0.15 | -$4.57 | -4.42 | $2.28 M | $2.06 M |
| 08/18/2023 | Q2 2023 | -$0.75 | -$2.90 | -2.15 | $2.06 M | $2.25 M |
| 05/15/2023 | Q1 2023 | -$0.30 | -$0.09 | 0.21 | $2.66 M | $2.25 M |
| 03/27/2023 | Q4 2022 | -$0.90 | -$2.86 | -1.96 | $2.51 M | $2.53 M |
| 11/07/2022 | Q3 2022 | -$1.80 | -$0.91 | 0.89 | $3.30 M | $2.40 M |
| 07/25/2022 | Q2 2022 | -$1.35 | -$1.99 | -0.64 | $2.93 M | $3.28 M |
| 05/09/2022 | Q1 2022 | -$1.35 | -$1.75 | -0.4 | $2.21 M | $3.24 M |
| 03/28/2022 | Q4 2021 | -$1.80 | -$1.44 | 0.36 | $2.10 M | $2.39 M |
| 10/25/2021 | Q3 2021 | -$0.13 | -$2.39 | -2.26 | $1.99 M | $2.55 M |
| 07/26/2021 | Q2 2021 | -$1.05 | -$4.76 | -3.71 | $2.28 M | $1.90 M |
| 04/26/2021 | Q1 2021 | -$0.45 | -$1.21 | -0.76 | $2.74 M | $3.05 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Earnings: FAQ's
The conference call for 's latest earnings report can be listened to online.
The conference call transcript for 's latest earnings report can be read online.
(:MEDS) has a recorded annual revenue of $431.61 M.
(:MEDS) has a recorded net income of $-41,512,264,000. has generated $-2.7 earnings per share over the last four quarters.
(:MEDS) has a price-to-earnings ratio of -0.03 and price/earnings-to-growth ratio is 0.